0.16
+2.03%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Klea Holding
Its shares trade on Euronext Paris under the ticker ALKLH.PA. It has been listed since 5 July 2011. In the fiscal year to 31 December 2025, it reported revenue of €22.2m and net income of €2.3m. At that date it held total assets of €37.3m and shareholders' equity of €27.6m.
Visiomed Group SA is engaged in the designing, developing, manufacturing and selling of healthcare medical devices. The company is headquartered in Paris, Ile-De-France. The company went IPO on 2011-07-05. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm sells its products to pharmacies, health professionals (hospitals, clinics and retirement homes) and to retail chains. Its brand names include ThermoFlash and BewellConnect, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 5 Jul 2011
- Employees
- 59
- Website
- visiomed-lab.com ↗
Leadership
Pay as last reported
- Mr. Guillaume BremondChairman of the Board
- Mr. Clement PacaudChief Executive Officer, Director, since 2024
- Mr. Raphael SmilaDirector
- Ms. Anne GaignardIndependent Director
- Mr. Axel RichebraqueIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Visiomed Group SA has several key strengths that contribute to its success in the market. Firstly, the company has a strong portfolio of innovative medical devices and healthcare solutions that are technologically advanced and cater to various medical needs. This positions Visiomed as a leader in the industry, fostering trust among healthcare professionals and patients.
- Secondly, the company has established strategic partnerships and collaborations with renowned medical institutions and professionals. This enables Visiomed to stay updated with the latest industry trends, access valuable resources, and expand its reach in the market.
Weaknesses
- Despite its strengths, Visiomed Group SA faces certain weaknesses that need to be addressed. One weakness is its limited geographic presence, primarily focused on specific regions or countries. This lack of global reach may hinder the company's growth potential and limit its market share in comparison to competitors with a wider international presence.
- Additionally, Visiomed's heavy reliance on a few key products or product lines may make the company vulnerable to market fluctuations or potential disruptions in those specific segments.
Opportunities
- Visiomed Group SA has several opportunities that can further enhance its market position and profitability. The increasing global demand for advanced medical technologies and remote healthcare services presents a significant growth opportunity for the company. By continuing to innovate and expand its product offerings in these areas, Visiomed can tap into new markets and gain a competitive advantage.
- Moreover, the growing emphasis on preventive healthcare and wellness provides an opportunity for Visiomed to develop and promote innovative solutions that encourage individuals to monitor their health proactively. This can help the company capture a larger customer base and increase its revenue streams.
Threats
- Like any other company, Visiomed Group SA faces certain threats that could impact its performance. The rapidly evolving regulatory environment and compliance requirements pose a significant challenge for the healthcare industry. Adapting to these changes and ensuring compliance may require additional resources and investments.
- Furthermore, the competitive landscape is intense, with numerous companies striving to gain market share in the medical device industry. This intensifying competition could potentially reduce pricing power and put pressure on Visiomed's profit margins.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.